Company news

Neovasc Inc news in 2020

Neovasc Inc's news releases, calls and decks from 2020, newest first.

View company

Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention

December 17, 2020

Neovasc Announces First Neovasc Reducer(TM) Implants in France

December 15, 2020

Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

December 14, 2020

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

December 10, 2020

Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-The-Market

December 10, 2020

Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market

December 8, 2020

Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series

December 1, 2020

Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum

November 16, 2020

Neovasc Announces Third Quarter Financial Results

November 5, 2020

Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina

October 28, 2020

Neovasc to Report Third Quarter Financial Results on November 5, 2020

October 22, 2020

Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020

October 13, 2020

Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

September 8, 2020

Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

September 3, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

August 17, 2020

Neovasc Provides Corporate Update

August 13, 2020

Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market

August 12, 2020

Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market

August 10, 2020

Neovasc Announces Second Quarter Financial Results

August 6, 2020

Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper

July 24, 2020

Neovasc Announces Partial Prepayment of Convertible Debenture

July 23, 2020

Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer(TM) Device

July 9, 2020

Neovasc Provides Update on Second Quarter Results

July 6, 2020

Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences

June 29, 2020

Neovasc Announces Positive Interim Results from REDUCER-I Study

June 26, 2020

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

June 25, 2020

Neovasc Announces Closing of $11.5 Million Registered Direct Offering Priced At-The-Market

June 16, 2020

Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market

June 12, 2020

Neovasc Reducer(TM) and Tiara(TM) Program to be Highlighted at Leading Industry Virtual Conferences

June 9, 2020

Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million

June 4, 2020

Neovasc Reducer Spotlighted in Leading German Public Television Program

June 3, 2020

Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System

May 27, 2020

Neovasc Provides Corporate Update

May 26, 2020

Neovasc Announces Offering of Convertible Debt and Warrants for Gross Proceeds of up to US$5.0 Million, Warrant Exchange Transaction and Repayment of 2017 Convertible Notes and Related Settlement

May 26, 2020

Neovasc Announces First Quarter Financial Results

May 7, 2020

Neovasc Announces Receipt of Nasdaq Extension to Satisfy Market Cap Rule

May 1, 2020

Neovasc to Report First Quarter Financial Results on May 7, 2020

April 23, 2020

Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results

March 30, 2020

Neovasc to Report Fourth Quarter and Full Year 2019 Financial Results on March 30, 2020

March 17, 2020

Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference

March 4, 2020

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

March 3, 2020

Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff

February 20, 2020

Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020

February 18, 2020

Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System

February 12, 2020

Neovasc Initiates Independent Inquiry into Trading of Its Shares

February 11, 2020

Neovasc Provides Update on Nasdaq Compliance

February 3, 2020

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer(TM) for Treatment of Refractory Angina

January 31, 2020

Neovasc Announces Executive Steering Committee for Transfemoral Trans-Septal Tiara Program

January 28, 2020

Neovasc Advances New Transfemoral Trans-Septal Tiara Design Concept After Further Successful Tests

January 24, 2020

Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany

January 22, 2020

Older news releases →

Decks in 2020